Recurrent Oral and Scrotal Inflammatory Lesions in A Young Man: First Case Report of Behcet’s Disease in Gambia

Article Sidebar

PDF
Published: Mar 16, 2022
DOI: https://doi.org/10.47191/ijmscrs/v2-i3-04
Keywords:
Behcet’s disease, canker sore, scrotal ulcer. The Gambia.

Main Article Content

Asmell Ramos Cabrera
HOD Internal Medicine Department, American International University West Africa
Yanet Correa Lopez
Mariana Grajales Faculty of Health Sciences.
Hector Oscar Victoria Barzaga
Carlos J Finlay Faculty of Health Sciences
Lamin Drammeh
Researcher of MRC. London school of hygiene and tropical medicine

Abstract

Behcet’s disease (BD) is a rare condition, considered as a variable vessel vasculitis with multi-system involvement, characterized by the triad of recurrent mouth and genital ulcers with eye involvement, also may involve joints, skin, central nervous system, and gastrointestinal tract with important heterogeneity among patients regarding demographic features and organ manifestations. BD has a worldwide distribution. However, it is observed commonly among populations living along the historic Silk Road.The etiology of the disease remains unknown, but the most widely held hypothesis of disease pathogenesis is that of a profound inflammatory response triggered by an infectious agent in a genetically susceptible host. Number of reported cases is inexplicably low in sub-Saharan region and especially lowest in West Africa where only few cases have been reported. The aim of this presentation is to announce the first case description of BD in Gambia as well as, to sensitize physicians, Internal Medicine residents and general practitioners in our sub region with the pattern of the disease, as only way to reduce the diagnosis time frame

Article Details

How to Cite
Cabrera, A. R., Lopez, Y. C., Barzaga, H. O. V. ., & Drammeh, L. (2022). Recurrent Oral and Scrotal Inflammatory Lesions in A Young Man: First Case Report of Behcet’s Disease in Gambia. International Journal of Medical Science and Clinical Research Studies, 2(3), 211–217. https://doi.org/10.47191/ijmscrs/v2-i3-04
Issue
Vol. 2 No. 3 (2022): Volume 02 Issue 03 March 2022
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Dilsen N. History and development of Behçet's disease. Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):512-9. PMID: 8896069.

II. Alpsoy E. Behçet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016; 43:620–32. doi:10.1111/1346-8138.13381

III. Ahmed Z, Rossi ML, Yong S, Martin DK, Walayat S, Cashman M, Tsoraides S, Dhillon S. Behçet's disease departs the 'Silk Road': a case report and brief review of literature with geographical comparison. J Community Hosp Intern Med Perspect. 2016; 6:30362. doi:10.3402/jchimp. v6

. 30362.eCollection2016

IV. H. Keino and A. Okada, “Behcet's disease: global epidemiology of an Old Silk Road disease,” British Journal of Ophthalmology, vol. 91, pp. 1573–1574, 2007.View at: Google Scholar

V. F. Davatchi, F. Shahram, C. Chams-Davatchi et al., “Behcet's disease: from east to west,” Clinical Rheumatology, vol. 29, no. 8, pp. 823–833, 2010.View at: Publisher Site | Google Scholar

VI. Mahr A, Maldini C. Epidemiology of Behçet’s disease. Rev Med Interne. 2014; 35:81–9.

VII. Deligny C, Antonio L, Merle H, et alTHU0206 Population-based epidemiology and description of behcet’s disease in the african descent population of martinique, french west indies Annals of the Rheumatic Diseases 2013;71:225.

VIII. Savey L, Resche-Rigon M, Wechsler B, et al. Ethnicity and association with disease manifestations and mortality in Behçet’s disease. Orphanet J Rare Dis. 2014; 9:42. doi:10.1186/1750-1172-9-42

IX. Ndiaye M, Sow AS, Valiollah A, Diallo M, Diop A, Alaoui RA, Diatta BA, Ly F, Niang SO, Dieng MT, Kane A. Behçet's disease in black skin. A retrospective study of 50 cases in Dakar. J Dermatol Case Rep. 2015; 9:98–102. doi:10.3315/jdcr.2015.1213

X. Liozon, Eric & Roussin, Cedric & Puéchal, Xavier & Garou, Alain & Valadier, Philippe & Périnet, Ian & Raffray, Loic & Théry, Yves & Lagarde, Bruno. (2011). Behcet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: A case series from Mayotte (Comoros). Joint, bone, spine: revue du rhumatisme. 78. 166-70.

1016/j.jbspin.2010.05.007.

XI. Davatchi F, Chams-Davatchi C, Ghodsi Z, Shahram F, Nadji A, Shams H, Akhlaghi M, Larimi R, Sadeghi-Abdolahi B. Diagnostic value of pathergy test in Behcet's disease according to the change of incidence over the time. Clin Rheumatol. 2011 Sep; 30(9):1151-5. doi: 10.1007/s10067-011-1694-5. Epub 2011 Mar 2. PMID: 21365194.

XII. Sequeira FF, Daryani D. The oral and skin pathergy test. Indian J Dermatol Venereol Leprol 2011; 77:526-530

XIII. Y. Yazici, S. Yurdakul, and H. Yazici, “Behçet’s syndrome,” Current Rheumatology Reports, vol. 12, no. 6, pp. 429–435, 2010.View at: Publisher Site | Google Scholar

XIV. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. Behçet’s syndrome: a critical digest of the 2014–2015 literature. Clin Exp Rheumatol. 2015; 33:3–14.

XV. Leonardo NM, McNeil J. Behcet's disease: is there geographical variation? A review far from the Silk Road. Int J Rheumatology. 2015; 2015:945262. doi:10.1155/2015/945262

XVI. Alpsoy E, Zobuboulis CC, Ehrlich CE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007; 48:573–585.

XVII. R. S. Tunes, T. C. Anjos, G. B. Martins, E. R. M. Barreto, and M. B. Santiago, “Prevalence of Behcet's syndrome in patients with recurrent aphthous ulcerations in Brazil,” Rheumatology International, vol. 29, no. 8, pp. 875–878, 2009.View at: Publisher Site | Google Scholar

XVIII. Bellakhal S, Ajili F, Boussetta N, et alAB0481 Clinical features of tunisian patients with behçet’s disease: a retrospective monocentric study. Annals of the Rheumatic Diseases 2013;72: A936.

XIX. Baş Y, Seçkin HY, Kalkan G, Takcı Z, Önder Y, Çıtıl R, Demir S, Şahin Ş. Investigation of Behçet's disease and recurrent aphthous stomatitis frequency: the highest prevalence in Turkey. Balkan Med J. 2016; 33:390–5. doi:10.5152/balkanmedj.2016.15101

XX. Ozguler Y, Hatemi G, Pala AS, et al POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET

XXI. Omaa O, Berriche O, Arfa S, et al AB0723 JUVENILE BEHCET’S DISEASE: WHICH

PARTICULARITIES? Annals of the Rheumatic Diseases 2021; 80:1393.

XXII. N. Düzgün and A. Ateş, “Erosive arthritis in a patient with Behçet's disease,” Rheumatology International, vol. 23, no. 5, pp. 265–267, 2003.View at: Publisher Site | Google Scholar

XXIII. S. Benamour, B. Zeroual, and F.-Z. Alaoui, “Joint manifestations in Behcet's disease: a review of 340 cases,” Revue du Rhumatisme, vol. 65, no. 5, pp. 299–307, 1998.View at: Google Scholar

XXIV. A. El Maghraoui, F. Tabache, A. Bezza et al., “A controlled study of sacroiliitis in Behçet's disease,” Clinical Rheumatology, vol. 20, no. 3, pp. 189–191, 2001.View at: Publisher Site | Google Scholar

XXV. Goloeva R, Alekberova ZAB0588.

GASTROINTESTINAL INVOLVEMENT OF BEHCET’S DISEASE IN RUSSIA. Annals of the Rheumatic Diseases 2019; 78:1755-1756.

XXVI. B. Coskun, Y. Saral, A. Gödekmerdan, I. Erden, and N. Coskun, “Activation markers in Behçet's disease,” Skinmed, vol. 4, no. 5, pp. 282–286, 2005.View at: Publisher Site | Google Scholar

XXVII. Chen Y, Lai Y, Yen Y, et al. Uveitis as a potential predictor of acute myocardial infarction in patients with Behcet’s disease: a population-based cohort studyBMJ Open 2021;11:e042201. doi:

1136/bmjopen-2020-042201

XXVIII. Özdemir Işik Ö, Şan S, Yazici A, et alAB0359 CRANIAL INVOLVEMENT IN BEHÇET’S DISEASE Annals of the Rheumatic Diseases 2021;80:1204-1205

XXIX. HPR NEUROLOGICAL MANIFESTATIONS DURING THE BEHCET DISEASE Annals of the Rheumatic Diseases 2019; 78:2166.

XXX. Maggio MC, Corsello G. FMF is not always "fever": from clinical presentation to "treat to target". Ital J Pediatr. 2020 Jan 15;46(1):7. doi: 10.1186/s13052-019-0766-z. PMID: 31941537; PMCID: PMC6961393.

XXXI. Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev. 2014 Apr-May;13(4-5):388-90.

doi: 10.1016/j.autrev.2014.01.045. Epub 2014 Jan 11. PMID: 24424166

XXXII. Goloeva R, Alekberova ZAB0765 PHENOTYPES OF BEHCET’S DISEASE IN DIFFERENT ETHNIC GROUPS Annals of the Rheumatic Diseases 2021;80:1409.

XXXIII. Bonitsis NG, Luong Nguyen LB, LaValley MP, Papoutsis N, Altenburg A, Kötter I, Micheli C, Maldini C, Mahr A, Zouboulis CC. Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford). 2015; 54:121–33.

doi:10.1093/rheumatology/keu247

XXXIV. Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 2015; 74:1636–44. Autoinflammatory Diseases 'Not So Rare After All,' Expert Says - Medscape - Jul 23, 2021.

XXXV. Goloeva R, Alekberova Z, Tankovskyi V, et alAB0772 Ocular manifestations of behcet’s disease. Annals of the Rheumatic Diseases 2013; 71:682.

XXXVI. Gündüz Ö, Gürler A, TuğrulAyanoğlu B, Erdoğan FG, Alhan A. Epidemiological properties of Behçet’s disease who had been followed up at Behçet’s disease center. TürkiyeKlinikleri J Dermatol. 2015; 25:85–91.

XXXVII. .Davari P, Rogers RS, Chan B, Nagler TH, Fazel N. Clinical features of Behçet's disease: A retrospective chart review of 26 patients. J Dermatol Treat. 2016; 27:70–4. doi:10.3109/09546634.2015.1054781

XXXVIII. D. Bang, S. Oh, K.-H. Lee, E.-S. Lee, and S. Lee, “Influence of sex on patients with Behçet's disease in Korea,” Journal of Korean Medical Science, vol. 18, no. 2, pp. 231–235, 2003.View at: Publisher Site | Google Scholar

XXXIX. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD), “The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria,” Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 3, pp. 338–347, 2014.View at: Publisher Site | Google Scholar

XL. International Study Group for Behçet's Disease, “Criteria for diagnosis of Behçet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990.View at: Publisher Site | Google Scholar

XLI. F. Davatchi, “Diagnosis/classification criteria for behcet's disease,” Pathology Research International, vol. 2012, Article ID 607921, 5 pages, 2012.View at: Publisher Site | Google Scholar

XLII. A. Mahr, L. Belarbi, B. Wechsler et al., “Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3951–3959, 2008.View at: Publisher Site | Google Scholar.

XLIII. https://www.healio.com/news/rheumatology/20200713/behcets-disease-remains-largely-unknown-among-physicians?utm_source=TrendMD&utm_medium=cpc&utm_campaign=Healio__TrendMD_

XLIV. A. Eguia, M. Villarroel, R. Martínez-Conde, M.A. Echebarria, J.M. Aguirre. Adamantiades-Behcet disease: an enigmatic process with oral manifestations.Med Oral Patol Oral Cir Bucal., 11 (2006), pp. E6-11

XLV. Gueudry J, Leclercq M, Saadoun D, Bodaghi B. Old and New Challenges in Uveitis Associated with Behçet's Disease. J Clin Med. 2021 May 26;10(11):2318. doi: 10.3390/jcm10112318. PMID: 34073249; PMCID:

PMC8198480.

XLVI. Santos D. Exploring the clinical understanding of Behçet disease. Talk presented at: Interdisciplinary Autoimmune Summit 2020; July 12, 2020; virtual.

XLVII. F. Davatchi, C. Chams-Davatchi, Z. Ghodsi et al., “Diagnostic value of pathergy test in Behcet's disease according to the change of incidence over the time,” Clinical Rheumatology, vol. 30, no. 9, pp. 1151–1155, 2011.View at: Publisher Site | Google Scholar